Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.

McCaughan, F; Pole, JC; Bankier, AT; Konfortov, BA; Carroll, B; Falzon, M; Rabbitts, TH; George, PJ; Dear, PH; Rabbitts, PH

Abstract:

RATIONALE: Amplification of distal 3q is the most common genomic aberration in squamous lung cancer (SQC). SQC develops in a multistage progression from normal bronchial epithelium through dysplasia to invasive disease. Identifying the key driver events in the early pathogenesis of SQC will facilitate the search for predictive molecular biomarkers and the identification of novel molecular targets for chemoprevention and therapeutic strategies. For technical reasons, previous attempts to analy...

Expand abstract

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

McCaughan, F., Pole, J. C., Bankier, A. T., Konfortov, B. A., Carroll, B., Falzon, M., Rabbitts, T. H., George, P. J., Dear, P. H., & Rabbitts, P. H. (2010). Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. American Journal of Respiratory and Critical Care Medicine, 182(1), 83–91.

MLA Style

McCaughan, F., et al. “Progressive 3q Amplification Consistently Targets SOX2 in Preinvasive Squamous Lung Cancer.” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 1, 2010, pp. 83–91.

Chicago Style

McCaughan, F, JC Pole, AT Bankier, BA Konfortov, B Carroll, M Falzon, TH Rabbitts, PJ George, PH Dear, and PH Rabbitts. 2010. “Progressive 3q Amplification Consistently Targets SOX2 in Preinvasive Squamous Lung Cancer.” American Journal of Respiratory and Critical Care Medicine 182 (1): 83–91.
Tweet
Print